Precision Oncology and Cancer Biomarkers : Issues at Stake and Matters of Concern / / edited by Anne Bremer, Roger Strand
| Precision Oncology and Cancer Biomarkers : Issues at Stake and Matters of Concern / / edited by Anne Bremer, Roger Strand |
| Autore | Bremer Anne |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (288 p.) |
| Disciplina | 610.1 |
| Altri autori (Persone) | StrandRoger |
| Collana | Human Perspectives in Health Sciences and Technology |
| Soggetto topico |
Medicine - Philosophy
Bioethics Cancer Public health Medical economics Philosophy of Medicine Cancer Biology Public Health Health Economics |
| ISBN | 3-030-92612-5 |
| Classificazione | BUS069000MED050000MED062000MED078000PHI005000 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction (Anne Bremer and Roger Strand) -- Chapter 1. Precision oncology in the news (Mille Stenmarck and Irmelin Nilsen) -- Chapter 2. Cancer biomarkers from a patient’s perspective (Karen Gissum) -- Chapter 3. Breast cancer: reconstruction of trouble (Hanna Dillekås) -- Chapter 4. HER2: an apparently ‘simple’ biomarkers revealing the complexities and uncertainties of precision oncology (Elisabeth Wik, Anne Bremer and Lars A. Akslen) -- Chapter 5. Integrating genomic and non-genomic factors in shaping the personal fingerprint in personalised cancer treatments (Mariano Bizzari and Andrea Pensotti) -- Chapter 6. Systems medicine and perspectives on precision oncology (Rune Kleppe, Inge Jonassen and Roger Strand) -- Chapter 7. Precision oncology: the challenges related to publishing (Maria Lie Lotsberg) -- Chapter 8. Filled with Desire, Perceive Molecules (Caroline Engen and Roger Strand) -- Chapter 9. Precision health and ethical ambiguity: How much cancer can we afford to prevent? (Leonard Fleck) -- Chapter 10. New cancer drugs and the public controversy: how can biomarkers contribute? (Eirik Tranvåg and Roger Strand) -- Chapter 11. Assessing the cost-effectiveness of targeted therapies and checkpoint inhibitors (John Cairns) -- Chapter 12. Real-world data in Health Technology Assessment of targeted cancer therapy (Jiyeon Kang) -- Chapter 13. Negotiating safety and resources in a first in human cancer trial in Denmark (Line Hillersdal) -- Conclusion: Precision oncology: Fact or fantasy? (Roger Strand and Anne Bremer). |
| Record Nr. | UNINA-9910555236203321 |
Bremer Anne
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Translations of Responsibility : Innovation Governance in Three European Regions
| Translations of Responsibility : Innovation Governance in Three European Regions |
| Autore | Völker Thomas |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | 2023 |
| Descrizione fisica | 1 online resource (243 pages) |
| Altri autori (Persone) |
SlaattelidRasmus
StrandRoger |
| Collana | History and Philosophy of Technoscience Series |
| Soggetto topico |
Nonfiction
History |
| Soggetto non controllato | Responsible Research and Innovation |
| ISBN |
9781003848868
1003848869 9781003848844 1003848842 |
| Classificazione | HIS010000HIS037030 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910832998203321 |
Völker Thomas
|
||
| 2023 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||